**Core Concept**
Succinylcholine is a depolarizing neuromuscular blocking agent used in anesthesia and emergency medicine to facilitate endotracheal intubation and provide muscle relaxation. Its pharmacokinetic profile is characterized by a short duration of action, which is primarily due to its rapid metabolism by a specific enzyme.

**Why the Correct Answer is Right**
Succinylcholine is rapidly hydrolyzed by the enzyme plasma cholinesterase (also known as pseudocholinesterase) to its metabolite succinylmonocholine. This enzymatic reaction occurs in the plasma and is responsible for the short duration of action of succinylcholine. The rapid hydrolysis of succinylcholine by plasma cholinesterase prevents its prolonged action on the nicotinic acetylcholine receptors, thereby limiting its neuromuscular blocking effects. The metabolism of succinylcholine is highly dependent on the activity of plasma cholinesterase, and genetic variations in this enzyme can affect the duration of action of the drug.

**Why Each Wrong Option is Incorrect**
**Option A:** Rapid excretion is not the primary reason for the short duration of action of succinylcholine. While excretion does play a role in the elimination of the drug, it is not the primary mechanism responsible for its short duration of action.
**Option B:** Poor absorption is not relevant to the pharmacokinetic profile of succinylcholine. Succinylcholine is well absorbed after intravenous administration, and its short duration of action is not due to poor absorption.
**Option D:** None of the above is incorrect because one of the options (rapid hydrolysis) is indeed the correct answer.

**Clinical Pearl / High-Yield Fact**
Genetic variations in plasma cholinesterase can lead to prolonged apnea after succinylcholine administration, especially in patients with atypical pseudocholinesterase. This is a clinically significant consideration in patients with a history of previous prolonged apnea after succinylcholine administration.

✓ Correct Answer: C. Rapid hydrolysis